The Eurofins network of companies, a global leader in food, environment, pharmaceutical and cosmetic product testing and in discovery pharmacology, forensics, advanced material sciences and agroscience contract research services, announces the completion of the acquisition of Manara Medical Laboratories, a state-of-the-art clinical diagnostics laboratory located in the Kingdom of Bahrain.
Known as ‘Eurofins Manara Medical Laboratories WLL’ going forward, the laboratory will deliver specialised and innovative clinical diagnostic testing solutions to Bahrain’s growing population, serving the Kingdom’s local clinical diagnostic testing needs and contributing to every stage of patient care from genetic predisposition to prevention, diagnostics, treatment monitoring and prognosis.
The approximately 3000-square-foot facility houses state-of-the-art equipment, performing efficient, high-quality testing, including STAT testing that expedites results for high-priority and time critical tests. This acquisition will further strengthen the Eurofins network’s rapidly developing presence in highly specialised and molecular clinical diagnostic testing and represents the first Eurofins laboratory in the Kingdom of Bahrain.
Eurofins Manara Medical Laboratories WLL’s approach to clinical diagnostics champions excellence, innovation and technological investment and offers testing services across many areas of health including biological sample analysis, diagnosing diseases and supporting medical decisions by analysing biological samples such as blood and urine, women’s health, supporting women during pregnancy with the most innovative non-Invasive Prenatal Tests (NIPT), as well as specialised genetic, hormonal and immunological tests, infertility diagnoses, and predisposition testing for common cancers.
Additionally, Eurofins Manara Medical Laboratories WLL will offer transplantation related testing, supporting transplant patients with histocompatibility testing, donor screening, microbiology and infectious disease testing, immunosuppression management, early detection of graft rejection, drug monitoring, and oncology related tests, through an advanced suite of molecular diagnostics solutions for personalised cancer care using state of-the-art technology.
Through this acquisition, the Eurofins network will service Bahrain’s rapidly growing healthcare market. Healthcare businesses operating in Bahrain adopt a proactive approach to research and have established advanced healthcare facilities operated by highly skilled and expert teams. Bahrain has positioned itself as a centre for modern medicine, offering high-quality healthcare locally and regionally.